Allergic rhinitis in children: Diagnosis and management strategies

Pediatric Drugs

Volumn 6, Issue 4, 2004, Pages 233-250

  Berger, William E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Allergy & Asthma Associates of Northern California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; AZELASTINE; BECLOMETASONE; CETIRIZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; DESLORATADINE; DIPHENHYDRAMINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCABASTINE; LORATADINE; MONTELUKAST; VACCINE; ZAFIRLUKAST;

ALLERGIC RHINITIS; ASTHMA; ATOPY; CHILD; CLINICAL FEATURE; CONJUNCTIVITIS; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DRUG POTENCY; ECONOMIC ASPECT; FOLLOW UP; HEALTH SURVEY; HUMAN; IMMUNOTHERAPY; INCIDENCE; LONG TERM CARE; PATHOPHYSIOLOGY; PHARYNGITIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHINITIS; RHINORRHEA; SEASONAL VARIATION; SEX DIFFERENCE; SIDE EFFECT; SINUSITIS; STATISTICAL SIGNIFICANCE; TONSILLITIS; UNITED STATES; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; CHILD, PRESCHOOL; HISTAMINE H1 ANTAGONISTS; HUMANS; INCIDENCE; PREVALENCE; RHINITIS, ALLERGIC, PERENNIAL;

EID: 6044220195     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00148581-200406040-00003     Document Type: Review

References (264)

1. Wright AL, Holberg CJ, Martinez FD, et al. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics 1994 Dec; 94 (6): 895-901
2. Newacheck PW, Stoddard JJ. Prevalence and impact of multiple childhood chronic illnesses. J Pediatr 1994; 124: 40-8
3. Bousquet J, the Allergic Rhinitis and its Impact on Asthma (ARIA) Workshop Group. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 Nov; 108 (5): S147-336
4. Dykewicz M, Fineman S. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998 Nov; 81 (Pt II): 478-518
5. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001 Jul; 108 (1): S45-53
6. Arrighi HM, Cook CK, Redding GJ. The prevalence and impact of allergic rhinitis among teenagers [abstract]. J Allergy Clin Immunol 1996; 97: 430
7. Juniper EF. Impact of upper respiratory allergic diseases on quality of life. J Allergy Clin Immunol 1998 Feb; 101 (2): S386-91
8. Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol 1997 Feb; 99 (2): S773-80
9. Fineman SM. The burden of allergic rhinitis: beyond dollars and cents. Ann Allergy Asthma Immunol 2002 Apr; 88 (4 Suppl. 1): 2-7
10. Howarth PH. Is allergy increasing? Early life influences. Clin Exp Allergy 1998; 28 Suppl. 6: 2-7
11. Varner AE. The increase in allergic respiratory diseases: survival of the fittest? Chest 2002 Apr; 121 (4): 1308-16
12. Howarth PH, Holmberg K. Allergic rhinitis: an increasing clinical problem. Allergy 1995; 50 Suppl. 23: 4-5
13. Sly RM. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol 1999 Mar; 82: 233-52
14. D'Amato G, Liccardi G, D'Amato M, et al. The role of outdoor air pollution and climatic changes on the rising trends in respiratory allergy. Respir Med 2001; 95: 606-11
15. Diaz-Sanchez D, Tsien A, Casillas A, et al. Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. J Allergy Clin Immunol 1996; 98: 114-23
16. Evans III R. Epidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis. In: Middleton Jr E, Reed CE, Ellis EF, et al., editors. Allergy: principles and practice. 4th ed. St Louis (MO): Mosby Year-Book, 1993: 1109-36
17. Salvi S. Pollution and allergic airways disease. Curr Opin Allergy Clin Immunol 2001; 1: 35-41
18. Von Mutius E, Martinez FD, Nicolai T, et al. Prevalence of asthma and atopy in two areas of West and East Germany. Am J Respir Crit Care Med 1994; 149: 358-64
19. Bjorksten B. Risk factors in early childhood for the development of atopic diseases. Allergy 1994; 49: 400-7
20. Von Mutius E. Environmental factors influencing the development and progression of pediatric asthma. J Allergy Clin Immunol 2002 Jun; 109 (6): S525-32
21. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001 Jul; 108 (1): S2-8
22. Freeman GL, Johnson S. Allergic diseases in adolescents. Am J Dis Child 1964; 107: 549-59
23. Hagy GW, Settipane GA. Bronchial asthma, allergic rhinitis and allergy skin tests among college students. J Allergy 1969; 44: 323-32
24. Hagy GW, Settipane GA. Risk factors for developing asthma and allergic rhinitis: a 7 year follow-up study of college students. J Allergy Clin Immunol 1976; 58: 330-6
25. Greisner III WA, Settipane RJ, Settipane GA. Co-existence of asthma and allergic rhinitis: a 23-year follow-up of college students. Allergy Asthma Proc 1998; 19: 185-9
26. Broder I, Higgins MW, Mathews KP, et al. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. J Allergy Clin Immunol 1974; 54: 100-10
27. Gergen PJ, Turkeltaub PC. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-1980 (NHANES II). J Allergy Clin Immunol 1992; 90: 579-88
28. Aberg N. Asthma and allergic rhinitis in Swedish conscripts. Clin Exp Allergy 1989; 19: 59-63
29. Rimpela AH, Savonius B, Rimpela MK, et al. Asthma and allergic rhinitis among Finnish Adolescents in 1977-1991. Scand J Soc Med 1995; 23 (1): 60-5
30. International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998 Apr 25; 351: 1225-32
31. Vanna AT, Yamada E, Arruda LK, et al. International study of asthma and allergies in childhood: validation of the rhinitis symptom questionnaire and prevalence of rhinitis in schoolchildren in Sao Paulo, Brazil. Pediatr Allergy Immunol 2001; 12: 95-101
32. Vichyanond P, Sunthornchart S, Singhirannusorn V, et al. Prevalence of asthma, allergic rhinitis and eczema among university students in Bangkok. Respir Med 2002; 96: 34-8
33. Goh DY, Chew FT, Quek SC, et al. Prevalence and severity of asthma, rhinitis, and eczema in Singapore schoolchildren. Arch Dis Child 1996; 74: 131-5
34. Kaur B, Anderson HR, Austin J, et al. Prevalence of asthma symptoms, diagnosis, and treatment in 12-14-year-old children across Great Britain (international study of asthma and allergies in childhood, ISAAC UK). BMJ 1998; 316: 118-24
35. Austin JB, Kaur B, Anderson HR, et al. Hay fever eczema, and wheeze: a nationwide UK study (ISAAC, international study of asthma and allergies in childhood). Arch Dis Child 1999; 81: 225-30
36. Shamssain MH, Shansian N. Prevalence and severity of asthma, rhinitis, and atopic eczema in 13- to 14-year-old schoolchildren from the northeast of England. Ann Allergy Asthma Immunol 2001 Apr; 86: 428-32
37. Lack G. Pediatric allergic rhinitis and comorbid disorders. J Allergy Clin Immunol 2001 Jul; 108 (1): S9-15
38. Fireman P. Therapeutic approaches to allergic rhinitis: treating the child. J Allergy Clin Immunol 2000; 105: S616-21
39. Lieberman P. Rhinitis. In: Slavin RG, Reisman RE, editors. Expert guide to allergy and immunology. Philadelphia (PA): American College of Physicians, 1999: 23-40
40. Skoner DP, Doyle WJ, Fireman P. Eustachian tube obstruction (ETO) after histamine nasal provocation: a double-blind dose-response study. J Allergy Clin Immunol 1987; 79: 27-31
41. Skoner DP, Doyle WJ, Chamovitz AH, et al. Eustachian tube obstruction after intranasal challenge with house dust mite. Arch Otolaryngol Head Neck Surg 1986; 112: 840-2
42. Friedman RA, Doyle WJ, Casselbrant MT, et al. Immunologic-mediated eustachian tube obstruction: a double-blind crossover study. J Allergy Clin Immunol 1983; 71: 442-7
43. Knight LC, Eccles R, Morris S. Seasonal allergic rhinitis and its effects on eustachian tube function and middle ear pressure. Clin Otolaryngol 1992; 17: 308-12
44. Corren J. Allergic rhinitis and asthma: how important is the link? J Allergy Clin Immunol 1997; 99: S781-6
45. Leynaert B, Neukirch F, Demoly P, et al. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000; 106: S201-5
46. Vinuya RZ. Upper airway disorders and asthma: a syndrome of airway inflammation. Ann Allergy Asthma Immunol 2002; 88 (4 Suppl. 1): 8-15
47. Smith JM. Epidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis (eczema). In: Middleton Jr E, Reed CE, Ellis EF, editors. Allergy: principles and practice. 2nd ed. St Louis (MO): Mosby Year-Book, 1983: 771-803
48. Eggleston PA. Upper airway inflammatory diseases and bronchial hyperresponsiveness. J Allergy Clin Immunol 1988; 81: 1036-41
49. Grossman J. One airway, one disease. Chest 1997; 111 (2): 11S-6S
50. Corren J. The impact of allergic rhinitis on bronchial asthma. J Allergy Clin Immunol 1998; 101: S352-6
51. Leynaert B, Bousquet J, Neukirch C, et al. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects. J Allergy Clin Immunol 1999; 104: 301-4
52. Braman SS, Barrows AA, DeCotiis BA, et al. Airway hyperresponsiveness in allergic rhinitis: a risk factor for asthma. Chest 1987; 91: 671-4
53. Rachelefsky GS. National guidelines needed to manage rhinitis and prevent complications. Ann Allergy Asthma Immunol 1999; 82: 296-305
54. Corren J, Adinoff AD, Irvin CG. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol 1992; 89: 611-8
55. Togias A. Systemic cross-talk between the lung and the nose. Am J Respir Crit Care Med 2001; 164: 726-7
56. Passalacqua G, Ciprandi G, Canonica GW. The nose-lung interaction in allergic rhinitis and asthma: united airways disease. Curr Opin Allergy Clin Immunol 2001; 1: 7-13
57. Kapsali T, Horowitz E, Diemer F, et al. Rhinitis is ubiquitous in allergic asthmatics. J Allergy Clin Immunol 1997; 99: S138
58. Neukirch F, Pin I, Knani J, et al. Prevalence of asthma and asthma-like symptoms in three French cities. Respir Med 1995; 89: 685-92
59. Van Arsdel Jr PP, Motulsky AG. Frequency and hereditability of asthma and allergic rhinitis in college students. Acta Genet 1959; 9: 101-14
60. Pedersen PA, Weeke ER. Asthma and allergic rhinitis in the same patients. Allergy 1983; 38: 25-9
61. Maternowski CJ, Mathews KP. The prevalence of ragweed pollinosis in foreign and native students at a Midwestern university and its implications concerning methods for determining inheritance of atopy. J Allergy 1962; 33: 130-40
62. Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994; 15: 21-5
63. Plaschke PP, Janson C, Norrman E, et al. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med 2000; 162: 920-4
64. Grant JA, Nicodemus CF, Findlay SR, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995; 95: 923-32
65. Aaronson DW. Evaluation of cetirizine in patients with allergic rhinitis and perennial asthma. Ann Allergy Asthma Immunol 1996; 76: 440-6
66. Baena-Cagnani CE. Desloratadine activity in concurrent seasonal allergic rhinitis and asthma. Allergy 2001; 56: 21-7
67. Corren J, Harris AG, Aaronson D, et al. Efficacy and safety of loratadine plus pseudoephedrine inpatients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol 1997; 100: 781-8
68. Welsh PW, Stricker WE, Chu C-P, et al. Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 1987; 62: 125-34
69. Corren J, Adinoff AD, Buchmeier AD, et al. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992; 90: 250-6
70. Watson WTA, Becker AB, Simons FER. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993; 91: 97-101
71. Malling HJ, Weeke B. Immunotherapy: position paper of the European Academy of Allergology and Clinical Immunology. Allergy 1993; 48 Suppl.: 9-35
72. Des Roches A, Paradis L, Menardo J-L, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract: VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997; 99: 450-3
73. Jacobsen L, Dreborg S, Moller C, et al. Immunotherapy as a preventive treatment [letter]. J Allergy Clin Immunol 1996; 97: 232
74. Walker SM, Pajno GB, Lima MT, et al. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol 2001; 107: 87-93
75. Yawn BP, Yunginger JW, Wollan PC, et al. Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol 1999 Jan; 103 (1): 54-9
76. Rachelefsky GS, Goldberg M, Katz RM, et al. Sinus disease in children with respiratory allergy. J Allergy Clin Immunol 1978; 61: 310-4
77. Shapiro GG. The role of nasal airway obstruction in sinus disease and facial development. J Allergy Clin Immunol 1988; 82: 935-40
78. Lund VJ, Kennedy DW. Quantification for staging sinusitis. Ann Otol Rhinol Laryngol Suppl 1995; 167: 17-21
79. Corren J, Rachelefsky GS. Interrelationship between sinusitis and asthma. Immunol Allergy Clin North Am 1994; 14: 171-84
80. Virant FS. Sinusitis and pediatric asthma. Pediatr Ann 2000; 29: 434-7
81. Gottlieb MJ. Relation of intranasal disease in the production of bronchial asthma [letter]. JAMA 1925; 95: 105
82. Chobot R. The incidence of sinusitis in asthmatic children. Am J Dis Child 1930; 39: 257-64
83. Weille FL. Studies in asthma: nose and throat in 500 cases of asthma [abstract]. N Engl J Med 1936; 215: 235
84. Furukawa CT, Shapiro GG, Rachelefsky GS. Children with sinusitis. Pediatrics 1983 Jan; 71 (1): 133-4
85. Cunningham MJ, Chiu EJ, Landgraf JM, et al. The health impact of chronic recurrent rhinosinusitis in children. Arch Otolaryngol Head Neck Surg 2000 Nov; 126: 1363-8
86. Rachelefsky GS, Katz RM, Siegel SC. Chronic sinus disease with associated reactive airway disease in children. Pediatrics 1984 Apr; 73: 526-9
87. Senior BA, Kennedy DW. Management of sinusitis in the asthmatic population. Ann Allergy Asthma Immunol 1996 Jul; 77: 6-19
88. Friedman R, Ackerman M, Wald E, et al. Asthma and bacterial sinusitis in children. J Allergy Clin Immunol 1984; 74: 185-9
89. Slavin RG. Asthma and sinusitis. J Allergy Clin Immunol 1992; 90: 534-7
90. Businco L, Fiore L, Frediani T, et al. Clinical and therapeutic aspects of sinusitis in children with bronchial asthma. Int J Pediatr Otorhinolaryngol 1981; 3: 287-94
91. Oliveira CA, Sole D, Naspitz CK, et al. Improvement of bronchial hyperresponsiveness in asthmatic children treated for concomitant sinusitis. Ann Allergy Asthma Immunol 1997 Jul; 79: 70-4
92. Kaliner MA, Osguthorpe JD, Fireman P, et al. Sinusitis: bench to bedside. J Allergy Clin Immunol 1997 Jun; 99 (6): S829-48
93. Damm M, Quante G, Jungehuelsing M, et al. Impact of functional endoscopic sinus surgery on symptoms and quality of life in chronic rhinosinusitis. Laryngoscope 2002 Feb; 112: 310-5
94. Parsons DS, Philips SE. Functional endoscopic surgery in children: a retrospective analysis of results. Laryngoscope 1993 Aug; 103: 899-903
95. Cummings NP, Wood RW, Lere JL, et al. Effect of treatment of rhinitis/sinusitis on asthma: results of a double-blind study [abstract]. Pediatr Res 1983; 17: 373A
96. Manning SC, Wasserman RL, Silver R, et al. Results of endoscopic sinus surgery in pediatric patients with chronic sinusitis and asthma. Arch Otolaryngol Head Neck Surg 1994 Oct; 120: 1142-5
97. Malone DC, Lawson KA, Smith DH, et al. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997; 99: 22-7
98. Blaiss MS. How to determine the cost-effectiveness of available allergic rhinitis treatments. Drug Benefit Trends 1999; 10 (6): 32-6
99. McMenamin P. Costs of hay fever in the United States in 1990. Ann Allergy 1994 Jul; 73: 36-9
100. Meltzer EO, Tyrell RJ, Rich D, et al. A pharmacologic continuum in the treatment of rhinorrhea: the clinician as economist. J Allergy Clin Immunol 1995 May; 95 (5): 1147-52
101. Ray NF, Baraniuk JN, Thamer M, et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses. J Allergy Clin Immunol 1999 Mar; 103 (3): 401-7
102. Taylor WR, Newacheck PW. Impact of childhood asthma on health. Pediatrics 1992; 90: 657-62
103. Grupp-Phelan J, Lozano P, Fishman P. Health care utilization and cost in children with asthma and selected comorbidities. J Asthma 2001; 38: 363-73
104. Naclerio RM, Baroody F. Understanding the inflammatory processes in upper allergic airway disease and asthma. J Allergy Clin Immunol 1998; 101: S345-51
105. Wang D, Smitz J, Waterschoot S, et al. An approach to the understanding of the nasal early-phase reaction induced by nasal allergen challenge. Allergy 1997; 52: 162-7
106. Wang D, Clement P, Smitz J, et al. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure. Int Arch Allergy Immunol 1995; 106: 278-85
107. Kay AB. Humoral and cellular mechanisms of airway inflammation. Prog Resp Res 1990; 24: 35-59
108. Baraniuk JN. Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 1997; 99: S763-72
109. Knani J, Campbell A, Enander I, et al. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. J Allergy Clin Immunol 1992; 90: 880-9
110. Togias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol 2000; 105: S599-604
111. Bachert C. Histamine: a major role in allergy? Clin Exp Allergy 1998; 28 Suppl. 6: 15-9
112. White MV, Kaliner MA. Mediators of allergic rhinitis. J Allergy Clin Immunol 1992; 90: 699-704
113. Kohi F, Miyagawa H, Agrawal DK, et al. Generation of leukotriene B4 and C4 from granulocytes of normal controls, allergic rhinitis, and asthmatic subjects. Ann Allergy 1990; 65: 228-32
114. Howarth PH, Salagean M, Dokic D. Allergic rhinitis: not purely a histamine-related disease. Allergy 2000; 55: 7-16
115. Pawankar R. Mast cells as orchestrators of the allergic reaction: the IgE-IgE receptor mast cell network. Curr Opin Allergy Clin Immunol 2001; 1: 3-6
116. Meltzer EO, Zeiger RS, Schatz M, et al. Chronic rhinitis in infants and children: etiologic, diagnostic, and therapeutic considerations. Pediatr Clin North Am 1983; 30: 847-71
117. Cook PR, Nishioka GJ. Allergic rhinosinusitis in the pediatric population. Otolaryngol Clin North Am 1996; 29: 39-56
118. Howarth PH. The cellular basis for allergic rhinitis. Allergy 1995; 50 Suppl. 23: 6-10
119. Knapp HR, Murray JJ. Leukotrienes as mediators of nasal inflammation. Adv Prostaglandin Thromboxane Leukot Res 1994; 22: 279-88
120. Raphael GD, Baraniuk JN, Kaliner MA. How and why the nose runs. J Allergy Clin Immunol 1991; 87: 457-67
121. Dahlen S-E, Bjork J, Hedqvist P, et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci 1981; 78: 3887-91
122. Bisgaard H, Olsson P, Bende M. Leukotriene D4 increases nasal blood flow in humans. Prostaglandins 1984; 27: 599-604
123. Samuelsson B. An elucidation of the arachidonic acid cascade: discovery of prostaglandins, thromboxane, and leukotrienes. Drugs 1987; 33 Suppl. 1: 2-9
124. 1-antagonists as a tool in clarifying the pathophysiology of nasal allergy. Clin Exp Allergy 1990; 20 Suppl. 2: 25-9
125. Okuda M, Watase T, Mezawa A, et al. The role of leukotriene D4 in allergic rhinitis. Ann Allergy 1988; 60: 537-40
126. Weiss JW, Drazen JM, McFadden ER. Airway constriction in normal humans produced by inhalation of leukotriene D. JAMA 1983 May; 249 (20): 2814-7
127. Borish L. The role of leukotrienes in upper and lower airway inflammation and the implications for treatment. Ann Allergy Asthma Immunol 2002 Apr; 88 (4 Suppl. 1): 16-22
128. Luster AD. Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-45
129. Demoly P, Sahla M, Campbell AM, et al. ICAM-1 expression in upper respiratory mucosa is differentially related to eosinophil and neutrophil inflammation according to the allergic status. Clin Exp Allergy 1998; 28: 731-8
130. Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985; 313: 65-70
131. Despot JE, Lemanske RF. Inflammatory mediators in allergic rhinitis. Immunol Allergy Clin North Am 1987; 7: 37-55
132. Durham SR. The inflammatory nature of allergic disease. Clin Exp Allergy 1998; 28 Suppl. 6: 20-4
133. Ayars GA, Altman LC, McManus MM, et al. Injurious effect of the eosinophil peroxide-hydrogen peroxide-halide system and major basic protein on human nasal epithelium in vitro. Am Rev Respir Dis 1989; 140: 125-31
134. Settipane GA. Rhinitis: introduction. In: Settipane GA, editor. Rhinitis. Providence (RI): Oceanside Press Publications, 1991: 1-14
135. Lieberman P. Rhinitis. In: Lieberman P, editor. Current practice of medicine: allergy and immunology. Oxford: Churchill-Livingstone, 1999: 295-315
136. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989 Nov 18; 299 (6710): 1259-60
137. Croner S, Kjellman NIM, Eriksson B, et al. IgE screening in 1701 newborn infants and the development of atopic disease during infancy. Arch Dis Child 1982; 57: 364-8
138. Marks MB. Significance of discoloration in the lower orbitopalpebral grooves in allergic children (allergic shiners). Ann Allergy 1963; 21: 26-32
139. Kulig M, Klettke U, Wahn V, et al. Development of seasonal allergic rhinitis during the first 7 years of life. J Allergy Clin Immunol 2000; 106: 832-9
140. Arshad SH, Tariq SM, Matthews S, et al. Sensitization to common allergens and its association with allergic disorders at age 4 years: a whole population birth cohort study. Pediatrics 2001; 108 (2): 461(e33)
141. International Rhinitis Management Working Group. International consensus report on the diagnosis and management of rhinitis. Allergy 1994; 49 Suppl. 19: 5-34
142. Meltzer EO. Treatment options for the child with allergic rhinitis. Clin Pediatr 1998; 37: 1-10
143. Schumacher MJ. Advances in tests for the evaluation of rhinitis. Immunol Allergy Clin North Am 1987; 7 (1): 15-35
144. Berger WE. Treatment update: allergic rhinitis. Allergy Asthma Proc 2001 Jul/ Aug; 22 (4): 191-8
145. Niederberger V, Stubner P, Spitzauer S, et al. Skin test results but not serology reflect immediate type respiratory sensitivity: a study performed with recombinant allergen molecules. J Invest Dermatol 2001 Oct; 117 (4): 848-51
146. Lieberman PL, Rakel RE, Hedges III HH, et al. Quantifying the incidence of mixed rhinitis with a new patient screening tool. Thera Trends 2002; 20: 221-32
147. Baena-Cagnani CE. Allergic rhinitis and its impact on asthma (ARIA) in Latin America [in Spanish]. Rev Alerg Mex 2002; 49: 181-8
148. Tovey E, Marks G. Methods and effectiveness of environmental control. J Allergy Clin Immunol 1999 Feb; 103 (2): 179-91
149. Wickman M, Korsgaard J. Transient sensitization to house-dust mites: a study on the influence of mite exposure and sex. Allergy 1996; 51: 511-3
150. Bousquet J, Lockey RF, Malling JH, et al. WHO position paper: allergen immunotherapy: therapeutic vaccines for allergic diseases. Eur J Allergy Clin Immunol 1998; 44: 23-7
151. Lärche M. Specific immunotherapy. Br Med Bull 2000; 45 (4): 1019-36
152. Jacobsen L. Preventive aspects of immunotherapy: prevention for children at risk of developing asthma. Ann Allergy Asthma Immunol 2001 Jul; 87 (1 Suppl. 1): 43-6
153. Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002 Feb; 109 (2): 251-6
154. Bousquet J, Demoly P, Michel F-B. Specific immunotherapy in rhinitis and asthma. Ann Allergy Asthma Immunol 2001 Jul; 87 (1 Suppl. 1): 38-42
155. Yang X. Does allergen immunotherapy alter the natural course of allergic disorders? Drugs 2001; 61 (3): 365-74
156. Adkinson Jr NF. Immunotherapy for allergic rhinitis. N Engl J Med 1999; 341 (7): 522-4
157. Malling H-J. Allergen-specific immunotherapy in allergic rhinitis. Curr Opin Allergy Clin Immunol 2001; 1: 43-6
158. Veling MC, Trevino RJ. The treatment of allergic rhinitis with immunotherapy: a review of 1000 cases. Ear Nose Throat J 2001 Aug; 80 (8): 542-3
159. Ross RR. Effectiveness of immunotherapy in the management of asthma: a metaanalysis of the literature. American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI), 1997 May. (Data on file)
160. Purello-D'Ambrosio F, Gangemi S, Merendino RA, et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not: a retrospective study. Clin Exp Allergy 2001; 31: 1295-302
161. Pajno GB, Barberio G, De Luca F, et al. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy: a six-year follow-up study. Clin Exp Allergy 2001; 31: 1392-7
162. Durham SR, Walker SM, Varga E-M, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-75
163. Eng PA, Reinhold M, Gnehm HPE. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 2002; 57: 306-12
164. Vinuya RZ. Specific allergen immunotherapy for allergic rhinitis and asthma. Pediatr Ann 2000; 29: 425-32
165. Wilson DR, Irani A-M, Walker SM, et al. Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium. Clin Exp Allergy 2001; 31: 1705-13
166. Furin MJ, Norman PS, Creticos PS, et al. Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol 1991 Jul; 88 (7): 27-32
167. Iliopoulos O, Proud D, Adkinson F, et al. Effects of immunotherapy on the early, late, and rechallenge nasal reactions to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991 Apr; 87 (4): 855-66
168. Otsuka H, Mezawa A, Ohnishi M, et al. Changes in nasal metachromatic cells during allergen immunotherapy. Clin Exp Allergy 1991; 21: 115-9
169. Kakinoki Y, Ohashi Y, Nakai Y, et al. Pollen immunotherapy inhibits T helper 1 and 2 cell responses, but suppression of T helper 2 cell response is a more important mechanism related to the clinical efficacy. Arch Otolaryngol Head Neck Surg 2000 Jan; 126: 63-70
170. Durham SR, Ying S, Varney VA, et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ. J Allergy Clin Immunol 1996 Jun; 97 (6): 1356-65
171. Wilson DR, Nouri-Aria KT, Walker SM, et al. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J Allergy Clin Immunol 2001 Jun; 107 (6): 971-6
172. De Amici M, Puggioni F, Casali L, et al. Variations in serum levels of interleukin (IL)-1β, IL-2, IL-6, and tumor necrosis factor-α during specific immunotherapy. Ann Allergy Asthma Immunol 2001 Mar; 86: 311-3
173. DuBuske LM. Appropriate and inappropriate use of immunotherapy. Ann Allergy Asthma Immunol 2001 Jul; 87 (1 Suppl. 1): 56-67
174. Lockey RF, Benedict LM, Turkeltaub PC, et al. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987 Apr; 79 (4): 660-77
175. Reid MJ, Lockey RF, Turkeltaub PC, et al. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993 Jul; 92 (1): 6-15
176. Lockey RF, Nicoara-Kasti GL, Theodoropoulos S, et al. Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol 2001 Jul; 87 (1 Suppl. 1): 47-55
177. Horak F. Seasonal allergic rhinitis. Drugs 1993; 45 (4): 518-27
178. Bahceciler NN, Isik U, Barlan IB, et al. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 2001; 32: 49-55
179. Hedlin G, Silber G, Naclerio R, et al. Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Clin Exp Allergy 1990; 20: 491-500
180. Di Rienzo V, Pagani A, Parmiani S, et al. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 1999; 54: 1110-3
181. Marcucci F, Sensi L, Frati F, et al. Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implications. Allergy 2001; 56: 1091-5
182. Caffarelli C, Sensi LG, Marcucci F, et al. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial. Allergy 2000; 55: 1142-7
183. Passalacqua G, Albano M, Riccio A, et al. Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: a double-blind, placebo-controlled trial. J Allergy Clin Immunol 1999; 104: 964-8
184. Mungan D, Misirligil Z, Burbus L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy of mite-sensitive patients with rhinitis and asthma: a placebo controlled study. Ann Allergy Asthma Immunol 1999; 82: 485-90
185. Kuehr J, Brauburger J, Zielen S, et al. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol 2002 Feb; 109 (2): 274-80
186. Lanier B. New treatments and the future role of immunotherapy: anti-IgE. Ann Allergy Asthma Immunol 2001; 87 (1 Suppl. 1): 68-9
187. Passalacqua G, Baena-Cagnani CE, Berardi M, et al. Oral and sublingual immunotherapy in paediatric patients. Curr Opin Allergy Clin Immunol 2003; 3: 139-45
188. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003; 111: 437-48
189. Di Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003; 33: 206-10
190. Frati F, Sensi L, Di Rienzo V, et al. A model for management of sublingual immunotherapy. Allerg Immunol (Paris) 2003; 35: 56-60
191. Della Volpe A, D'Agostino GW, Varricchio AM, et al. Sublingual allergen-specific immunotherapy in allergic rhinitis and related pathologies: efficacy in a paediatric population. Int J Immunopathol Pharmacol 2002; 15: 35-40
192. Storms WW. Rethinking our approach to allergic rhinitis management. Ann Allergy Asthma Immunol 2002 Apr; 88 (4 Suppl. 1): 30-5
193. Davies RJ, Bagnall AD, McCabe RN, et al. Antihistamines: topical vs oral administration. Clin Exp Allergy 1996; 26 Suppl. 3: 11-7
194. Slater JW, Zechnich AD, Haxby DG. Second-generation antihistamines: a comparative review. Drugs 1999; 57: 31-47
195. Howarth PH. Assessment of antihistamine efficacy and potency. Clin Exp Allergy 1999; 29 Suppl. 3: 87-97
196. Scadding GK. Clinical assessment of antihistamines in rhinitis. Clin Exp Allergy 1999; 29 Suppl. 3: 77-81
197. 1 receptor antagonists. Clin Pharmacokinet 1999; 36: 329-52
198. Cuss FM. Beyond the histamine receptor: effect of antihistamines on mast cells. Clin Exp Allergy 1999; 29 Suppl. 3: 54-9
199. Kreutner W, Hey JA, Anthes J, et al. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine Hi receptor antagonist: 1st communication. Receptor selectivity, antihistaminic activity, and antiallergenic effects. Arzneimittel Forschung 2000; 50: 345-52
200. Nayak AS, Schenkel E. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis. Allergy 2001; 56: 1077-80
201. Day J. Pros and cons of the use of antihistamines in managing allergic rhinitis. J Allergy Clin Immunol 1999; 103: S395-9
202. Miadonna A, Cottini M, Milazzo N, et al. In vivo and ex vivo inhibitory effects of loratadine on histamine release in patients with allergic rhinitis. Allergy 1998; 53: 1183-8
203. 1 antihistamines on adhesion molecules: a possible rationale for long-term treatment. Clin Exp Allergy 1999; 29 Suppl. 3: 49-53
204. Canonica GW, Ciprandi G. Minimal persistent inflammation may be controlled by cetirizine. Ann Allergy Asthma Immunol 1999; 83: 445-8
205. Simpson K, Jarvis B. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Drugs 2000; 59: 310-21
206. Markham A, Wagstaff AJ. Fexofenadine. Drugs 1998; 55: 269-74
207. Shichijo M, Inagaki N, Nakai N, et al. The effects of anti-asthma drugs on mediator release from cultured human mast cells. Clin Exp Allergy 1998; 28: 1228-36
208. 2-receptor antagonists. Exp Dermatol 2000; 9: 118-24
209. Geha RS, Meltzer EO. Desloratadine: a new, nonsedating, oral antihistamine. J Allergy Clin Immunol 2001; 107: 751-62
210. Agrawal DK. Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug. Expert Opin Investig Drugs 2001; 10: 547-60
211. Schroeder JT, Schleimer RP, Lichtenstein LM, et al. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy 2001; 31: 1369-77
212. Vuurman EFPM, van Veggel LMA, Uiterwijk MMC, et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 1993; 71: 121-6
213. Lassig W, Wober W, Hoflich C, et al. Topical therapy of allergic rhinitis in childhood: allergodil nasal spray: non-sedating in children. Curr Med Res Opin 1996; 13: 391-5
214. Shin MH, Baroody F, Proud D, et al. The effect of azelastine on the early allergic response. Clin Exp Allergy 1992; 22: 289-95
215. McNeely W, Wiseman LR. Intranasal azelastine: a review of its efficacy in the management of allergic rhinitis. Drugs 1998; 56: 91-114
216. Lieberman P. Management of allergic rhinitis with a combination antihistamine/anti-inflammatory agent. J Allergy Clin Immunol 1999; 103: S400-4
217. Chand N, Sofia RD. Azelastine: a novel in vivo inhibitor of leukotriene biosynthesis: a possible mechanisms of action. A mini review. J Asthma 1995; 32: 227-34
218. 4 release and production by bronchial asthmatic eosinophils. Respir Res 1990; 9: 206-12
219. Konno S-I, Adachi M, Asano K, et al. Inhibitory action of azelastine on cytokine production from human peripheral blood leukocytes in vitro. Life Sci 1993; 53: PL201-6
220. Konno S-I, Asano K, Okamoto K-I, et al. Inhibition of cytokine production from human peripheral blood leukocytes by anti-allergic agents in vitro. Eur J Pharmacol 1994; 264: 265-8
221. Yoneda K, Yamamoto T, Ueta E, et al. Suppression by azelastine hydrochloride of NF-κB activation involved in generation of cytokines and nitric oxide. Jpn J Pharmacol 1997; 73: 145-53
222. Ciprandi G, Pronzato C, Passalacqua G, et al. Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity. J Allergy Clin Immunol 1996; 98: 1088-96
223. Pronzato C, Ricca V, Varese P, et al. Evaluation of antiallergic activity of azelastine nasal spray [abstract]. Allergy 1995; 50: 69
224. Bahre M, Klimek L, Molich J, et al. Azelastine reduces release of eosinophil cationic protein (ECP) [abstract]. Allergy 1995; 50: 102
225. Meltzer EO. An overview of current pharmacotherapy in perennial rhinitis. J Allergy Clin Immunol 1995; 95: 1097-110
226. Pauwels R. Mode of action of corticosteroids in asthma and rhinitis. Clin Allergy 1986; 16: 281-8
227. Otsuka H, Denburg JA, Befus AD, et al. Effect of beclomethasone dipropionate on nasal metachromatic cell subpopulations. Clin Allergy 1986; 16: 589-95
228. Bascom R, Wachs M, Naclerio RM, et al. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988; 81: 580-9
229. Fahey JV, Guyre PM, Munck A. Mechanisms of antiinflammatory actions of glucocorticoids. Adv Inflammation Res 1981; 2: 21-51
230. Sim TC, Hilsmeier KA, Alam R, et al. Effect of topical corticosteroids on the recovery of histamine releasing factors in nasal washings of patients with allergic rhinitis. Am Rev Respir Dis 1992; 145: 1316-20
231. Meltzer EO. The pharmacological basis of the treatment of perennial allergic rhinitis and non-allergic rhinitis with topical corticosteroids. Allergy 1997; 52 Suppl. 36: 33-40
232. Holm AF, Fokkens WJ. Topical corticosteroids in allergic rhinitis; effects on nasal inflammatory cells and nasal mucosa. Clin Exp Allergy 2001; 31: 529-35
233. Parker M. Enhancer elements activated by steroid hormones? Nature 1983; 304: 687-8
234. Gillis S, Crabtree GR, Smith KA. Glucocorticoid-induced inhibition of T-cell growth factor production: I. The effect on mitogen-induced lymphocyte proliferation. J Immunol 1979; 123: 1624-31
235. Gillis S, Crabtree GR, Smith KA. Glucocorticoid-induced inhibition of T-cell growth factor production: II. The effect on in vitro generation of cytotoxic T-cells. J Immunol 1979; 123: 1631-5
236. Beutler B, Krochin N, Milsark IW, et al. Control of cachectin (tumor necrosis factor) synthesis; mechanisms of endotoxin resistance. Science 1986; 232: 977-80
237. Beutler B, Cerami C. Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocr Rev 1988; 9: 57-66
238. Guyre PM, Bodwell JE, Munck A. Glucocorticoid actions on the immune system: inhibition of production of an Fc-receptor augmenting factor. J Steroid Biochem 1981; 15: 35-9
239. Arya SK, Wong-Staal F, Gallo RC. Dexamethasone-mediated inhibition of human T-scell growth factor and interferon messenger RNA. J Immunol 1984; 133: 273-6
240. Wihl J-A. Topical corticosteroids and nasal reactivity. Eur J Respir Dis 1982; 63 Suppl. 122: 205-10
241. Kondo H, Nachtigal D, Frenkiel S, et al. Effect of steroids on nasal inflammatory cells and cytokine profile. Laryngoscope 1999; 109: 91-7
242. Weido A, Reece L, Alam R, et al. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis. Ann Allergy Asthma Immunol 1996; 77: 407-15
243. Alvarado C, Reed C, Bleich G. Fluticasone propionate reduces eosinophils and cytokines in nasal lavage fluid of patients with ragweed hay fever [abstract]. J Allergy Clin Immunol 1995; 95: 193
244. LaForce C. Use of nasal steroids in managing allergic rhinitis. J Allergy Clin Immunol 1999; 103: S388-94
245. Naclerio RM. Allergic rhinitis. N Engl J Med 1991; 125: 860-9
246. Fraunfelder FT, Meyer SM. Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids. Am J Opthalmol 1990; 109: 489-90
247. Skoner DP, Rachelefsky GS, Meltzer EO, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate [abstract no. e23]. Pediatrics 2000; 105: 415-6
248. Wolthers OD, Pedersen S. Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids. Acta Paediatr 1993; 82: 635-40
249. Skoner DP, Gentile D, Angelini B, et al. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis. Ann Allergy Asthma Immunol 2003; 90: 56-62
250. Schenkel EJ, Skoner DP, Bronsky EA, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furcate aqueous nasal spray [abstract no. e22]. Pediatrics 2000; 105: 415
251. Allen DB. Systemic effects of intranasal steroids: an endocrinologist's perspective. J Allergy Clin Immunol 2000; 106 (4 Suppl.): S179-90
252. Scadding GK. Corticosteroids in the treatment of pediatric allergic rhinitis. J Allergy Clin Immunol 2001; 108 (1 Suppl.): S59-64
253. Allen DB. Inhaled corticosteroid therapy for asthma in preschool children: growth issues. Pediatrics 2002; 109 (2 Suppl.): 373-80
254. Brand PL. Inhaled corticosteroids reduce growth: or do they? Eur Respir J 2001; 17: 287-94
255. Meltzer EO, Orgel HA, Bronsky EA, et al. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology. J Allergy Clin Immunol 1992; 90: 242-9
256. Dockhorn R, Aaronson D, Bronsky E, et al. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Ann Allergy Asthma Immunol 1999; 82: 349-59
257. van Adelsberg J, Philip G, LaForce CF, et al. Montelukast Spring Rhinitis Investigator Group: randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2003; 90: 214-22
258. Philip G, Malmstrom K, Hampel FC, et al. Montelukast Spring Rhinitis Study Group: montelukast for treating seasonal allergic rhinitis. A randomized, double-blind, placebo-controlled trial performed in the Spring. Clin Exp Allergy 2002; 32: 1020-8
259. Meltzer EO. Clinical evidence for antileukotriene therapy in the management of allergic rhinitis. Ann Allergy Asthma Immunol 2002; 88 (4 Suppl. 1): 23-9
260. Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized placebo-controlled clinical trial. J Allergy Clin Immunol 2000; 105: 917-22
261. Nayak AS, Philip G, Lu S, et al. Montelukast Fall Rhinitis Investigator Group: efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis. A multicenter, randomized, double-blind, placebo-controlled trial performed in the Fall. Ann Allergy Asthma Immunol 2002; 88: 592-600
262. Tkachyk SJ. New treatments for allergic rhinitis. Can Fam Physician 1999; 45: 1255-60
263. Nathan RA. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments. Ann Allergy Asthma Immunol 2003; 90: 182-90
264. Pullerits T, Praks L, Ristioja V, et al. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2002; 109: 949-55